Healthcare
Moderna Inc. (MRNA)
Moderna Inc. stock analysis and opportunity scoring
$218.01
As of Oct 16
↓ -7.82%
Moderna Inc. (MRNA) at a glance
Moderna Inc. (MRNA) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
MRNA last traded at $218.01 down 7.82% on the session as of 2026-10-16.
MKD Intelligence assigns MRNA a composite opportunity score of 57 out of 100, indicating mixed conditions across trend, momentum and volume factors.
The risk score for MRNA is 80 out of 100 (high), where a higher number means greater expected volatility.
Healthcare sector comparison
MRNA has a composite opportunity score of 57/100, below the 60.5/100 average across 84 tracked Healthcare stocks. RMD leads the sector at 78/100.
Price History
High
$236.50
Low
$154.04
Period
Oct 16 - Sep 18 (21d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’ - The New York Times
The New York Times · Oct 9
Moderna stock hits 4-year high on planned national cancer vaccine effort - Yahoo Finance
Yahoo Finance · Oct 9
Cancer Vaccines Are the N.I.H.’s Next ‘Big Bet’ - The New York Times
The New York Times · Oct 9
Why the FDA should not approve an ineffective multicancer screening test - STAT
STAT · Oct 6
Moderna Stock Hits a New High as CEO Says It’s More Than Covid Vaccines - Barron's
Barron's · Sep 25
Upcoming Events
Data as of Oct 19
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.